Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : son of T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (173)	9/16/1999 10:31:00 AM
From: Biomaven	Respond to of 673

QTRN is doing a number of interesting things outside from the pure CRO stuff: 1. They have an innovative contract with CVTX to market their cardiovascular drug candidate. Basically they are playing substitute big-pharma here, thus giving biotechs an alternative to partnering late-stage products. 2. They are aggressively trying to integrate information from payment info into their product sales. Thus on a sales call, they have a good idea what a particular doctor currently prescribes. They also get regional info, so know where to concentrate sales effort. 3. They are using the net a lot - e.g., link with Dr Koop to enroll patients for trials. My guess is that they will also use their insurance info to do recruitment for trials. They are also using the net for insurance verification and payment. So I kind of view them as a hidden net play. Peter